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MicroRNAs (miRNAs) are small RNAs that control gene expression, and are involved in the regulation of
fundamental biological processes including development, cell differentiation, proliferation, and apoptosis.
miRNAs regulate gene expression in normal hematopoiesis, and aberrant miRNA expression might contribute
to leukomogenesis. Specifically, miR-21 is abundantly expressed in various tumors including leukemia and
lymphoma, and is functionally involved in oncogenic processes. We investigated a role for miR-21 in Se´zary
Syndrome (SS), a cutaneous T-cell lymphoma (CTCL) with CD4þ tumor cells (Se´zary cells) present in the skin,
lymph nodes, and peripheral blood. It was shown previously that SS is characterized by constitutively activated
signal transducer and activator of transcription 3 (STAT3) signaling. In this study we show by chromatin
immunoprecipitation that miR-21 is a direct STAT3 target in Se´zary cells. Stimulation of Se´zary cells or healthy
CD4þ T cells with the common-g chain cytokine IL-21 results in a strong activation of STAT3, and subsequent
upregulation of miR-21 expression. Both pri- and mature miR-21 expression are increased in Se´zary cells when
compared with CD4þ T cells from healthy donors. Silencing of miR-21 in Se´zary cells results in increased
apoptosis, suggesting a functional role for miR-21 in the leukomogenic process. Consequently, miR-21 might
represent a therapeutic target for the treatment of SS.
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INTRODUCTION
Se´zary Syndrome (SS) is a rare leukemic cutaneous T-cell
lymphoma (CTCL) with an aggressive clinical course. It is
characterized by erythroderma, generalized lymphadenopa-
thy, and neoplastic skin-homing CD4þ memory T cells
(Se´zary cells) in the skin, lymph nodes, and peripheral blood
(Willemze et al., 2005). We previously performed a detailed
genomic analysis of SS and demonstrated that deregulation of
the common-g chain cytokine/signal transducer and activator
of transcription (STAT) signaling pathway might be one of the
molecular mechanisms involved in its pathogenesis (Vermeer
et al., 2008). The transcription factor family of STAT proteins
has a crucial regulatory role in numerous biological processes
such as cell proliferation, differentiation, and survival, and is
critical in malignant transformation and oncogenesis. STAT3
has been found to be activated inappropriately in a wide
range of human cancers (Yu and Jove, 2004). Also, in SS,
constitutive activation of STAT3 was demonstrated previously
(Nielsen et al., 1999; Eriksen et al., 2001; van Kester et al.,
2008; Zhang et al., 2008).
A functional role for STAT3 in oncogenic processes has
been demonstrated extensively. In Se´zary cells, inhibition of
STAT3 results in rapid apoptosis (Eriksen et al., 2001; van
Kester et al., 2008). STAT3 exerts its oncogenic effects by
transcriptional regulation of its target genes, and identifica-
tion of these targets is mandatory to understand fully the
pathophysiological role of STAT3 in oncogenesis. Potential
downstream STAT3 targets include genes that regulate cell
cycle progression, cell survival/growth, and angiogenesis.
It was recently shown that STAT3 can also regulate the
expression of the cancer-related microRNA-21 (miR-21) in
multiple myeloma (Loffler et al., 2007). miRNAs are non-
protein coding small RNAs that regulate gene expression via
post-transcriptional silencing of target genes. They are
transcribed as primary transcripts (pri-miRNA) that are
processed by Drosha in the nucleus to generate precursor
miRNA. This pre-miRNA is transported to the cytoplasm,
where it is subsequently processed by Dicer to yield
the mature miRNA. MiRNAs have important regulatory roles
in fundamental biological processes such as cell develop-
ment, differentiation, proliferation, and apoptosis, and
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hematopoiesis is also extensively regulated by miRNAs
(reviewed by Yendamuri and Calin, 2009). In addition,
miRNAs are crucially involved in tumorigenesis by control-
ling gene expression of oncogenes and tumor suppressors.
They have been found to be aberrantly expressed in many
types of cancer, including hematopoietic malignancies such
as leukemias and lymphomas (reviewed by Lawrie et al.,
2008; Yendamuri and Calin, 2009).
miR-21 is a miRNA that is frequently upregulated in
human cancers such as breast cancer, glioma, colorectal
cancer, and hepatocellular carcinoma, and in hematological
malignancies such as chronic lymphatic leukemia, acute
myeloid leukemia, B-cell lymphoma, and Hodgkin’s lym-
phoma (Krichevsky and Gabriely, 2009). Previous observa-
tions demonstrate an oncogenic role for miR-21: ectopic
overexpression of miR-21 increased tumor cell proliferation,
migration, and invasion, whereas inhibition of miR-21
expression reduced proliferation, tumor growth, and inva-
sion, while inducing apoptosis (reviewed by Krichevsky and
Gabriely, 2009).
In this study we demonstrate that miR-21 is a direct STAT3
target in Se´zary cells. In line with the previously described
deregulated STAT3 activation in Se´zary cells, we found that
expression of miR-21 is increased in neoplastic CD4þ cells
from Se´zary patients, whereas inhibition of miR-21 results in
increased apoptosis of Se´zary cells. Together, our results
suggest that miR-21 has a functional role in the pathogenesis
of SS.
RESULTS
STAT3 binds to the promoter of the miR-21 gene in Se´zary cells
Constitutive STAT3 activation in Se´zary cells is demonstrated
by various groups (Nielsen et al., 1999; Eriksen et al., 2001;
van Kester et al., 2008; Zhang et al., 2008), whereas this
activation is lost upon in vitro culturing (van Kester et al.,
2008). It was shown previously that STAT3 can be activated
in CTCL cells cultured in vitro by the common-g chain
cytokine IL-21 (Marzec et al., 2008). These results were
validated in our experimental systems. Culturing of Se´zary
cells with recombinant IL-21 results in a rapid and transient
increase in phosphorylated STAT3 levels, with a maximal
STAT3 activation after 15–30minutes (Figure 1a). Further-
more, pretreatment of cells with cucurbitacin I (CucI), an
inhibitor of the JAK/STAT3 signaling pathway (Blaskovich
et al., 2003), resulted in a complete block of STAT3 activation
by IL-21 (Figure 1b). Similar results were observed using
CD4þ cells isolated from the peripheral blood from healthy
donors, as well as in SeAx and HuT78, two continuous cell
lines derived from patients with SS (data not shown).
A STAT3 target gene that was described previously is the
gene encoding the primary transcript of miR-21 (Loffler et al.,
2007). We assayed whether miR-21 is also a direct STAT3
target in Se´zary cells. SeAx cells were treated with IL-21 to
activate STAT3, and analyzed by chromatin immunoprecipi-
tation (ChIP). Chromatin that was precipitated with STAT3
antibodies was significantly enriched for the miR-21 promo-
ter sequence when compared with chromatin precipitated
with normal rabbit IgG. In contrast, in SeAx cells not treated
with IL-21, hardly miR-21 promoter sequences were detected
in chromatin precipitated with STAT3 antibodies (Figure 2).
As a control, PCR was performed on the precipitated
chromatin for the promoter of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), a promoter that lacks STAT3
binding sites. No precipitation of the GAPDH promoter was
observed in SeAx cells cultured with or without IL-21
(Figure 2), demonstrating the specificity of the ChIP.
Expression of primary miR-21 is rapidly and transiently
increased upon STAT3 activation
Quantitative reverse transcriptase PCR (RT-PCR) analysis of
RNA isolated from freshly isolated Se´zary cells stimulated
with IL-21 showed that the expression of the primary miR-21






























Figure 1. IL-21 transiently induces signal transducer and activator of
transcription 3 (STAT3) activity in Se´zary cells. CD4þ T cells were isolated
from peripheral blood of Se´zary Syndrome (SS) patients. STAT3 activation was
assayed by flow cytometry using an antibody specific for phosphorylated
STAT3 (P-STAT3), and depicted as mean fluorescent intensity (MFI) of
duplicated measurements (mean±SD). (a) Se´zary cells were stimulated with
IL-21 for the time points indicated. (b) Cells were pretreated in vitro with
DMSO or cucurbitacin I (CucI) for 2 hours, and thereafter stimulated



























Figure 2. Signal transducer and activator of transcription 3 (STAT3) directly
binds the microRNA-21 (miR-21) promoter in Se´zary cells. SeAx cells
were cultured with or without IL-21 for 30minutes, and chromatin
immunoprecipitation (ChIP) was performed using antibodies against STAT3 or
normal rabbit IgG (NRIgG) as a negative control. Immunoprecipitated DNA
was used in quantitative PCR reactions with primers specific for the promoter
region of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or miR-21.
Bars represent mean±SD of duplicate measurements.
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with a maximum induction after 1 to 2 hours (Figure 3a). The
kinetics of this induction follows the transient induction of
STAT3 activation upon IL-21 stimulation (Figure 1a). A
similar induction of pri-miR-21 was observed after stimula-
tion of CD4þ T cells isolated from healthy controls (Figure
3b). To assay the STAT3 dependency of the pri-miR-21
induction by IL-21, cells were pretreated with CucI for
2 hours. Surprisingly, CucI treatment by itself consistently
induced pri-miR-21 expression (Figure 3c). Nevertheless,
induction of miR-21 expression by IL-21 was significantly
diminished after pretreatment of CD4þ T cells with CucI
when compared with pretreatment with the solvent DMSO
(Figure 3d). Similar results were obtained using isolated
CD4þ T cells from SS patients and healthy controls (Figure
3d). Collectively, our results suggest that the induction of pri-
miR-21 expression by IL-21 stimulation of CD4þ T cells is
dependent on the activation of STAT3.
Increased expression of miR-21 in Se´zary cells
MiR-21 expression has been found upregulated in many
different malignancies. We quantitatively compared miR-21
expression in CD4þ T cells isolated from SS patients and
healthy controls. As an additional control, we used CD4þ
cells that were isolated from patients with benign erythro-
derma (BE) secondary to atopic dermatitis. This cell popula-
tion consists of activated T cells, as evidenced by a
9-fold increased expression of the T-cell activation marker
CD25 when compared with CD25 expression in CD4þ
T cells from healthy donors (data not shown). Significant
increased pri-miR-21 expression was observed in SS patients
when compared with healthy controls and patients with BE
(Figure 4a). Interestingly, levels of mature miR-21 were
significantly increased in both patients with SS and BE when
compared with healthy controls (Figure 4b). Correlation
analysis (Pearson) revealed no correlation between the
expression levels of pri-miR-21 and mature miR-21 in the
individual patients and controls (data not shown).
Correlation of miR-21 expression with clinical characteristics
Careful examination of the pri-miR-21 expression levels in




































































































































Figure 3. Primary microRNA-21 (Pri-miR-21) expression is induced
by IL-21, dependent on STAT3 activation. CD4þ T cells were in vitro
stimulated by IL-21. Pri-miR-21 expression was assayed by quantitative
reverse transcriptase PCR (RT-PCR), and normalized for expression of RPS11.
Pri-miR-21 expression (mean±SD) from duplicate measurements is shown.
Representative examples of (a) two Se´zary Syndrome (SS) patients and (b) two
healthy controls are shown. (c) CD4þ T cells from SS patients (n¼ 2) and
healthy controls (n¼2) were treated with DMSO or cucurbitacin I (CucI)
for 2 hours. Bars represent pri-miR-21 expression (mean±SEM) relative to
levels in DMSO-treated cells. (d) CD4þ T cells from SS patients or healthy
controls were pretreated with DMSO or CucI for 2 hours, and subsequently
cultured with or without IL-21 for 1 hour. Pri-miR-21 expression was assayed
by RT-PCR and normalized for RPS11 expression. Symbols represent fold-
induction of pri-miR-21 expression by IL-21 for individual healthy controls































































Figure 4. MicroRNA-21 (miR-21) levels are elevated in Se´zary cells. RNA
and miRNA were extracted from CD4þ T cells isolated from peripheral
blood from healthy controls (HC), patients with benign erythroderma (BE), or
patients with Se´zary Syndrome (SS). (a) Pri-miR-21 expression was determined
by quantitative reverse transcriptase PCR (RT-PCR) and normalized for
expression of a stably expressed reference gene (RPS11). (b) Mature miR-21
expression was determined by TaqMan, and normalized for U6 and RNU44
expression. Each symbol represents the expression in an individual patient,
and the median is indicated with a horizontal line. Statistically significant
differences (Po0.05; Mann–Whitney) are indicated.
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subgroups of patients, that is, a group with slightly elevated
pri-miR-21 expression when compared with healthy controls
and patients with BE, and a group with extremely elevated
pri-miR-21 levels (Figure 4a). There was no obvious correla-
tion of the pri-miR-21 levels in these SS patients with clinical
parameters such as total leukocyte count, absolute numbers
of Se´zary cells in the peripheral blood, or CD4/CD8 ratio
(data not shown). Remarkably, the 3 patients with relative
low pri-miR-21 expression are all alive (median follow-up
10 months, range 10–14), whereas 4 out of 6 patients with
relative high pri-miR-21 expression died of their disease
(median follow-up 14 months, range 10–48), while 2 are still
alive (follow-up 7–54 months).
From the group of patients in whom mature miR-21 levels
were studied (Figure 4b), 4 of 5 patients are alive (median
follow-up 12 months, range 10–54), whereas 1 patient died of
disease (follow-up 11 months). Interestingly, this latter patient
displayed the highest level of mature miR-21 expression.
Summarizing, these initial observations suggest that miR-
21 expression levels might have a prognostic value.
Obviously, this should be verified in a larger group of SS
patients before conclusive statements can be made.
miR-21 is involved in regulation of apoptosis in Se´zary cells
The functional relevance of the increased miR-21 expression
for the survival of Se´zary cells was studied. MiR-21
expression was knocked down in SeAx cells by transfecting
the cells with anti-miR-21 oligonucleotides, and subse-
quently analyzed for apoptosis. Quantitative PCR analysis
of the transfected cells showed that miR-21 levels were
decreased by 80% when compared with untransfected
control cells (data not shown). Transfection of anti-miR-21
resulted in decreased numbers of viable cells, and increased
numbers of dead and apoptotic cells, when compared with
cells transfected with fluorescently labeled oligonucleotides
only, or with a negative control oligonucleotide (Figure 5).
These results clearly demonstrate a functional role for miR-21
in the regulation of apoptosis in Se´zary cells.
The tumor-suppressor gene phoshatase and tensin homo-
log (PTEN), is a validated miR-21 target in various malig-
nancies (Meng et al., 2006, 2007; Yamanaka et al., 2009).
Loss of PTEN was shown to be relevant in the pathogenesis of
T-cell malignancies, including CTCL (Scarisbrick et al.,
2000). We therefore assessed whether PTEN is a miR-21
target in Se´zary cells. Knockdown of miR-21 in Se´zary cells
did not alter PTEN protein or mRNA expression (data not
shown). In addition, the signaling pathway downstream of
PTEN was not affected by miR-21 knockdown as phosphory-
lated AKT levels were unaltered (data not shown). Combined,
these data argue against a role for PTEN as miR-21 target in
the regulation of Se´zary cell survival. Thus, the molecular
pathway by which miR-21 regulates apoptosis in Se´zary cells
is still elusive.
DISCUSSION
In this paper we demonstrate that the expression of miR-21 is
induced by IL-21 in CD4þ T cells, mediated via the
activation of STAT3. MiR-21 expression levels are signifi-
cantly elevated in CD4þ tumor cells from the peripheral
blood of patients with SS, and inhibition of miR-21 results in
apoptosis of Se´zary cells. Our results are schematically
summarized in Figure 6.
Previous microarray analysis of CTCL cells identified a
limited number of genes modulated by IL-21 stimulation
(Marzec et al., 2008). The miR-21 gene, shown in this study
to be a STAT3 target and induced upon IL-21 stimulation,



























Figure 5. Inhibition of microRNA-21 (miR-21) in Se´zary cells results in
increased apoptosis. SeAx cells were transfected with fluorescently labeled
oligonucleotides, in combination with anti-miR-21 oligonucleotides, or
negative control oligonucleotides. After 24 hours, apoptosis was assayed by
flow cytometric analysis for Annexin V and propidium iodide (PI). The
number of dead, living, and apoptotic cells was calculated as percentage of
the total number of transfected (¼ fluorescently labeled) cells. Bars denote





















Figure 6. Schematic model summarizing our results.
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probably caused by the rapid and transient nature of miR-21
induction as shown in this paper (Figure 3a and b), whereas
the microarray analysis to identify IL-21-responsive genes
was only conducted after 4 hours of IL-21 stimulation
(Marzec et al., 2008).
Various mechanisms can attribute to aberrant expression
of primary transcripts for miRNAs in cancer cells (reviewed
by Calin and Croce, 2007). Transcription of pri-miR-21 is
controlled by a promoter region that contains several
conserved elements, including binding sites for AP-1
(activator protein 1), Ets/PU.1, C/EBP-a (CCAAT/enhancer-
binding protein-a), p53, and STAT3 (Fujita et al., 2008). In
this study we demonstrate that in SS, miR-21 expression is
positively regulated by direct binding of STAT3. Similarly, it
was shown previously that in multiple myeloma cells,
induction of miR-21 expression by IL-6 is strictly STAT3
dependent (Loffler et al., 2007). Thus, increased miR-21
expression, as shown in this study, might well be a direct
consequence of constitutive activation of STAT3 in Se´zary
cells (Nielsen et al., 1999; Eriksen et al., 2001; van Kester
et al., 2008). In addition, chromosomal abnormalities can
contribute to deregulated gene expression in cancer. The
miR-21 gene is mapped to chromosome 17q23.2, and
amplification of this region is associated with a number of
cancers, including breast (Wu et al., 2000) and prostate
cancer (Kasahara et al., 2002), as well as Hodgkin’s
lymphoma (Chui et al., 2003). Our previous research showed
gain of the 17q23 region containing the miR-21 gene in 16/
20 of SS patients (Vermeer et al., 2008), as well as in the SeAx
cell line (data not shown). However, in the group of seven
patients for whom both pri-miR-21 expression and genomic
data are available, no clear correlation between these
parameters was observed (data not shown), indicating that
other transcription regulatory mechanisms are equally or
more important.
An additional level of regulation of miRNA expression is at
the level of processing primary miRNA transcripts into mature
miRNAs. Systematic evaluation showed that levels of pre-
and mature miR-21 correlated very well in numerous tissues,
cell lines, and tumors (Lee et al., 2008), suggesting that
expression of miR-21 is not dominantly regulated at the level
of processing by Dicer. In contrast, Drosha-mediated
cleavage of pri-miR-21 into pre-miR-21 is heavily regulated
(Davis et al., 2008). Thus, the lack of correlation between pri-
and mature miR-21 levels in SS, as described in this paper,
might well be caused by regulation at the level of Drosha
activity. To test this, it would be interesting to assay pre-miR-
21 expression in tumor cells from SS patients.
In this paper we demonstrate that inhibition of miR-21
induces apoptosis in Se´zary cells, similarly as demonstrated
for cell lines from various other malignancies (Chan et al.,
2005; Meng et al., 2006, 2007; Si et al., 2007; Zhu et al.,
2007; Fei et al., 2008; Frankel et al., 2008; Li et al., 2009).
mIR-21 mediates these effects by silencing its target genes.
mIR-21 targets validated independently by several research
groups include tumor suppressors such as programmed cell
death protein 4 (PDCD4), tropomyosin 1 (TPM1), and PTEN
(reviewed by Krichevsky and Gabriely, 2009). Knockdown of
miR-21 in Se´zary cells does not alter the expression of PTEN
or its downstream signaling component phospho-AKT (data
not shown), arguing against a role for PTEN as miR-21 target
in the regulation of Se´zary cell survival. Thus, the miR-21
target genes important in regulating apoptosis of Se´zary cells
remain to be identified.
Inhibition of miR-21 resulted in induction of apoptosis of
B20–25% of transfected Se´zary cells. In contrast, inhibition
of STAT3 using CucI resulted in apoptosis in 73–91% of
Se´zary cells (van Kester et al., 2008). This apparent
discrepancy might be caused by the contribution of other
STAT3 target genes besides miR-21. Among the STAT3 target
genes that were described previously, several function as
inhibitors of apoptosis (e.g., Bcl-xL (B-cell lymphoma-extra
large), Mcl-1 (myeloid cell leukemia sequence 1), and
survivin), and cell-cycle regulators (e.g., cyclin D1 and
c-myc).
In summary, we demonstrate that miR-21 is a direct STAT3
target in SS, and that constitutive STAT3 activation in Se´zary
cells, as shown previously (Nielsen et al., 1999; Eriksen et al.,
2001; van Kester et al., 2008; Zhang et al., 2008), is
accompanied by increased miR-21 expression. In numerous
cancers, overexpression of miR-21 has been reported
(Krichevsky and Gabriely, 2009), often associated with
constitutively activated STAT3 (Jing and Tweardy, 2005).
Therefore, the oncogenic properties of STAT3 are (at least
partly) mediated via miR-21. Although STAT3 has been
regarded as a promising therapeutic target for many years, its
clinical development has been hampered, generating a need
for reassessment of the ongoing strategies on the targeting of
STAT3 (Jing and Tweardy, 2005). The identification of miR-
21 as one of the oncogenic STAT3 downstream targets might




Patients with SS (2 males and 8 females, median age 67 years) were
diagnosed based on criteria of the WHO/EORTC 2005 classification
(Willemze et al., 2005). All patients presented with erythroderma, and
showed T-cell clonality in the peripheral blood with a CD4/CD8 ratio
of 410. As control groups, patients with erythroderma secondary to
atopic dermatitis (BE), and healthy donors were included.
Approval for these studies was obtained from the Leiden
University Medical Center review board, and informed consent
was provided according to the Declaration of Helsinki Principles.
Cell culturing and stimulation experiments
SeAx, a cell line derived from the peripheral blood of a patient with
SS (kindly provided by Dr K Kaltoft) (Kaltoft et al., 1987) was cultured
in RPMI-1640 (Invitrogen, Breda, The Netherlands), supplemented
with 10% fetal calf serum (HyClone/Greiner, Nu¨rtingen, Germany),
2mM L-glutamine (Invitrogen), 100Uml–1 penicillin, and 100mgml–1
streptomycin (Invitrogen), and 200Uml–1 IL-2 (PeproTech, Rocky
Hill, NJ). HuT78, a cell line derived from peripheral blood of a
patient with SS (ATCC number TIB-161) was cultured in RPMI-1640
supplemented with 10% fetal calf serum, 2mM L-glutamine,
100Uml–1 penicillin, and 100mgml–1 streptomycin.
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Heparinized blood was drawn from patients and controls, and
peripheral blood mononuclear cells were isolated by Ficoll density
centrifugation. Subsequently, CD4þ T cells were isolated by
negative selection with magnetic beads (CD4þ T-cell isolation kit,
Miltenyi Biotec, Bergisch Gladbach, Germany). The purity of the cell
population was determined by flow cytometry for CD3, CD4, and
CD8 expression, and was generally 485%. In addition, earlier
experiments demonstrated that 490% of the CD4þ cells comprise
malignant cells characterized by expression of a clonally rearranged
T-cell receptor.
Cells were cultured in RPMI-1640 supplemented with 10%
human AB serum (Greiner Bio-One, Alphen aan den Rijn, The
Netherlands), 2mM L-glutamine, 100Uml–1 penicillin, 100mgml–1
streptomycin, 200Uml–1 IL-2, and 5 ngml–1 IL-7 (PeproTech).
Cells used for stimulation experiments were grown overnight in
cytokine-deprived medium, and subsequently stimulated with IL-21
(100 ngml–1; ImmunoTools, Friesoythe, Germany) for the times
indicated. CucI (Indofin, Hillsborough, NJ) was dissolved in DMSO
at a concentration of 50mM, and diluted in culture medium to a final
concentration of 30 mM.
Flow cytometry
STAT3 activation was assayed by flow cytometry. Cells were fixed in
4% paraformaldehyde in phosphate-buffered saline for 15minutes at
room temperature. After washing with phosphate-buffered saline/
0.2% bovine serum albumin, cells were permeabilized in 90%
ice-cold methanol for 30minutes at 4 1C. After washing, cells were
stained with Alexa647-conjugated antibodies against phosphory-
lated STAT3 (BD Biosciences, Franklin Lakes, NY) for 20minutes
at 4 1C.
Flow cytometric analysis for apoptotic cells was performed by
staining cells with allophycocyanin-conjugated antibodies against
Annexin V and propidium iodide, using the apoptosis detection kit
(eBioscience, San Diego, CA).
Samples were acquired on a flow cytometer (FacsCalibur,
BD Biosciences), and analyzed using CellQuest software (BD
Biosciences).
Quantitative reverse transcriptase PCR
Expression levels of pri-miR-21 were assayed in total RNA samples
isolated from 1 to 10 106 cells using the RNeasy Mini kit (Qiagen,
Hilden, Germany). RNA (1mg) was treated with RQ1 DNase I
(Promega, Madison, WI) and converted into complementary DNA
using IScript reverse transcriptase (Bio-Rad, Hemel Hempstead, UK),
oligo(dT)1218, and random hexamer primers (Bio-Rad). Real-time PCR
was performed using the IQ5 instrument and SYBR Green Supermix
(Bio-Rad), using the following cycle parameters: 5minutes at 95 1C,
followed by 45 cycles of 15 seconds at 97 1C and 30 seconds at 60 1C.
Primer sequences for pri-miR-21 and RPS11 have been described
previously (Loffler et al., 2007; Vermeer et al., 2008). Data were
analyzed using IQ5 software using the DDCt method (Bio-Rad), and
expressed relative to RPS11 expression levels. Specificity of the PCR
products was confirmed by melting curve analysis.
For determining mature miR-21 expression levels, total RNA was
isolated from 1 to 10 106 cells using the mirVana RNA isolation kit
(Ambion, Austin, TX). Total RNA (150 ng) was used for reverse
transcriptase and subsequent pre-amplification reaction using
Megaplex primer pool A, according to the manufacturer’s protocol
(Applied Biosystems, Foster City, CA). The miRNA real-time PCR
was performed for miR-21, U6, and RNU44 using the TaqMan
miRNA assays and Universal PCR mastermix (Applied Biosystems)
on a IQ5 instrument (Bio-Rad), according to the manufacturer’s
protocol (Applied Biosystems). The cycle parameters were as
follows: 10minutes at 95 1C, followed by 40 cycles of 15 seconds
at 95 1C and 60 seconds at 60 1C. miR-21 expression was analyzed
using the DDCt method in the IQ5 software (Bio-Rad), and expressed
relative to U6 and RNU44 expression levels.
Chromatin immunoprecipitation
ChIP was performed using the EZ-ChIP kit (Upstate, Temecula, CA),
according to the manufacturer’s instruction. In short, SeAx cells were
grown overnight in medium deprived of cytokines. Cells were
incubated with or without IL-21 (50 ngml–1) for 30minutes at 37 1C,
immediately fixed in formaldehyde, and chromatin was sonicated
using the Bioruptor (Diagenode, Liege, Belgium). Immunoprecipita-
tion was performed using anti-STAT3 antibodies (Santa Cruz
Biotechnology, Santa Cruz, CA), or with control antibodies supplied
in the ChIP kit (anti-acetyl-Histone H3, or normal rabbit IgG).
Co-immunoprecipitated DNA was amplified using primers for the
GAPDH promoter, as supplied in the ChIP kit, or primers specific for
the upstream region of the miR-21 gene (Loffler et al., 2007). Real-
time PCR was performed using the IQ5 instrument and SYBR Green
Supermix (Bio-Rad), using the following cycle parameters: 6minutes
at 95 1C, followed by 45 cycles of 15 seconds at 96 1C, 30 seconds at
57 1C, and 30 seconds at 72 1C. Data were analyzed using IQ5
software using the DCt method (Bio-Rad). Specificity of the PCR
products was confirmed by melting curve analysis.
Transfection experiments
SeAx cells were transferred to medium without penicillin and
streptomycin. Next day, cells were transfected by Lipofectamine
2000 (Invitrogen), with 100nM fluorescently labeled oligonucleotides
(BLOCK-iT, Invitrogen) combined with 40nM anti-miR-21 miRNA
inhibitor (no. AM10206; Ambion) or negative control (negative
control no. 1: AM17010; Ambion). At 24hours after transfection,
cells were analyzed for apoptosis by flow cytometry.
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